Market Watch

News & Latest Press Releases
Welcome to Visiongain Market Watch. Here you’ll find unbiased reporting, market briefings and real-time industry commentary. Our incisive editorial voice draws on decades of expertise, interviews with market leaders and meticulous analysis to bring you news, articles and press stories that matter.
Precision Medicine RWE

Precision Medicine Meets Real-World Evidence

As 2025 unfolds, the next competitive advantage in precision medicine may no longer lie in discovery but in real-world validation. While genomics, AI, and advanced therapies have transformed the way diseases are targeted, Real-world Evidence (RWE) is reshaping how those breakthroughs earn market traction, reimbursement, and clinical adoption.
Read More

Biopharmaceuticals Contract Manufacturing Market

1 September 2025.

The global Biopharmaceuticals Contract Manufacturing market is projected to grow at a CAGR of 11.6% by 2035…Visiongain has published a new report entitled Biopharmaceuticals Contract Manufacturing Market Report 2025-2035(Including Impact of U.S. Trade Tariffs): Forecasts by Source (Mammalian, Non-mammalian), by Service ((Process Development (Downstream, Upstream), Fill & Finish Operations, Analytical & QC Studies, Packaging)), by Product ((Biologics (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Others), Biosimilars)), by Company Size (Small, Mid-sized, Large), by Scale of Operations (Preclinical, Clinical), by Therapeutic Area (Therapeutic Area, Oncology, Autoimmune Diseases, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Neurology, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies.

Precision Medicine Meets Real-World Evidence

6 August 2025.

As 2025 unfolds, the next competitive advantage in precision medicine may no longer lie in discovery but in real-world validation. While genomics, AI, and advanced therapies have transformed the way diseases are targeted, Real-world Evidence (RWE) is reshaping how those breakthroughs earn market traction, reimbursement, and clinical adoption.

Clients & Partners